首页> 美国卫生研究院文献>Cell Cycle >Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia
【2h】

Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia

机译:长期非编码RNA UCA1通过调节MiR-296-3P / Myc轴在急性髓性白血病中调节细胞增殖和细胞凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute myeloid leukemia (AML) is a common hematopoietic malignancy with a generally poor prognosis. Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been identified as an oncogene in various malignancies including AML. However, the role and mechanisms of UCA1 in AML tumorigenesis were incompletely understood. Hence, this study aims to investigate whether UCA1 regulates AML progression by miR-296-3p/Myc axis. Cell proliferation and apoptosis were evaluated by MTT assay and flow cytometry, respectively. Luciferase reporter assay was performed to analyze the interaction between miR-296-3p and UCA1 or Myc. The results showed that UCA1 knockdown inhibited proliferation and induced apoptosis in AML cells (U937 and HL60). Mechanistically, UCA1 acted as a sponge of miR-296-3p by binding to miR-296-3p. Myc, a target of miR-296-3p, was positively regulated by UCA1. Functional assay showed that the anti-AML effect of UCA1 knockdown could be abrogated by miR-296-3p inhibition and Myc overexpression. Moreover, UCA1 knockdown inhibited AML cell tumorigenesis in vivo, which was associated with regulation of miR-296-3p and Myc expression. In conclusion, UCA1 modulates AML progression by regulating miR-296-3p/Myc axis.
机译:急性髓性白血病(AML)是一种常见的造血恶性肿瘤,其预后普遍差。长期非编码RNA(LNCRNA)尿路上皮癌相关的1(UCA1)已被鉴定为包括AML的各种恶性肿瘤的癌基因。然而,UCA1在AML肿瘤发生中的作用和机制不完全理解。因此,本研究旨在调查UCA1是否通过MIR-296-3P / MYC轴调节AML进展。通过MTT测定和流式细胞术评估细胞增殖和细胞凋亡。进行荧光素酶报告器测定以分析miR-296-3P和UCA1或MYC之间的相互作用。结果表明,UCA1敲低抑制AML细胞(U937和HL60)中增殖和诱导细胞凋亡。机械地,UCA1通过与miR-296-3p结合时作为miR-296-3p的海绵。 Myc是miR-296-3p的目标,由UCA1积极调节。功能测定表明,MiR-296-3P抑制和MyC过表达可以消除UCA1敲低的抗AML效应。此外,UCA1敲低抑制体内的AML细胞肿瘤内核,其与miR-296-3p和Myc表达的调节有关。总之,UCA1通过调节miR-296-3p / myc轴来调节AML进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号